148 related articles for article (PubMed ID: 26095925)
21. Hydronephrosis in the course of ureteropelvic junction obstruction: An underestimated problem? Current opinions on the pathogenesis, diagnosis and treatment.
Krajewski W; Wojciechowska J; Dembowski J; Zdrojowy R; Szydełko T
Adv Clin Exp Med; 2017 Aug; 26(5):857-864. PubMed ID: 29068584
[TBL] [Abstract][Full Text] [Related]
22. Association between NDUFS1 from urinary extracellular vesicles and decreased differential renal function in children with ureteropelvic junction obstruction.
Bu L; Zhang L; Wang X; Du G; Wu R; Liu W
BMC Nephrol; 2024 May; 25(1):158. PubMed ID: 38720274
[TBL] [Abstract][Full Text] [Related]
23. Acoustic radiation force impulse (ARFI) elastography in the evaluation of renal parenchymal stiffness in patients with ureteropelvic junction obstruction.
Habibi HA; Cicek RY; Kandemirli SG; Ure E; Ucar AK; Aslan M; Caliskan S; Adaletli I
J Med Ultrason (2001); 2017 Apr; 44(2):167-172. PubMed ID: 27933438
[TBL] [Abstract][Full Text] [Related]
24. Activity of lysosomal exoglycosidases in the urine of healthy normotensive and pre-hypertensive children.
Zalewska-Szajda B; Taranta-Janusz K; Chojnowska S; Waszkiewicz N; Zwierz K; Wasilewska A
Adv Med Sci; 2019 Mar; 64(1):24-31. PubMed ID: 30312953
[TBL] [Abstract][Full Text] [Related]
25. Urinary proteome analysis in patients with stable SFU grade 4 ureteropelvic junction obstruction differs from normal.
Mesrobian HG; Kryger JV; Groth TW; Fiscus GE; Mirza SP
Urology; 2013 Sep; 82(3):745.e1-10. PubMed ID: 23987180
[TBL] [Abstract][Full Text] [Related]
26. Value of urinary carbohydrate antigen 19-9 to predict failure of conservative management in children with ureteropelvic junction obstruction.
Nabavizadeh B; Khorramirouz R; Amini E; Pishgar F; Hojjat A; Kajbafzadeh AM
J Pediatr Surg; 2019 Aug; 54(8):1650-1653. PubMed ID: 30340877
[TBL] [Abstract][Full Text] [Related]
27. Urinary and serum carbohydrate antigen 19-9 as a biomarker in ureteropelvic junction obstruction in children.
Kajbafzadeh AM; Elmi A; Talab SS; Emami H; Esfahani SA; Saeedi P
J Urol; 2010 Jun; 183(6):2353-60. PubMed ID: 20400153
[TBL] [Abstract][Full Text] [Related]
28. Impact of successful pediatric ureteropelvic junction obstruction surgery on urinary HIP/PAP and BD-1 levels.
Gupta S; Nicassio L; Junquera GY; Jackson AR; Fuchs M; McLeod D; Alpert S; Jayanthi VR; DaJusta D; McHugh KM; Becknell B; Ching CB
J Pediatr Urol; 2020 Oct; 16(5):592.e1-592.e7. PubMed ID: 32278658
[TBL] [Abstract][Full Text] [Related]
29. Lysosomal exoglycosidases in serum and urine of patients with pancreatic adenocarcinoma.
Dariusz Szajda S; Waszkiewicz N; Stypułkowska A; Dadan J; Zwierz K
Folia Histochem Cytobiol; 2010 Sep; 48(3):351-7. PubMed ID: 21071338
[TBL] [Abstract][Full Text] [Related]
30. Urinary cytokine profiles in unilateral congenital hydronephrosis.
Taranta-Janusz K; Wasilewska A; Dębek W; Waszkiewicz-Stojda M
Pediatr Nephrol; 2012 Nov; 27(11):2107-2113. PubMed ID: 22744767
[TBL] [Abstract][Full Text] [Related]
31. Urinary antimicrobial peptides: Potential novel biomarkers of obstructive uropathy.
Gupta S; Jackson AR; DaJusta DG; McLeod DJ; Alpert SA; Jayanthi VR; McHugh K; Schwaderer AR; Becknell B; Ching CB
J Pediatr Urol; 2018 Jun; 14(3):238.e1-238.e6. PubMed ID: 29706289
[TBL] [Abstract][Full Text] [Related]
32. Urinary heme oxygenase-1 in children with congenital hydronephrosis due to ureteropelvic junction obstruction.
Li Z; Liu X; Liu S; Gu C; Tian F; Wen J
Biomarkers; 2012 Aug; 17(5):471-6. PubMed ID: 22630328
[TBL] [Abstract][Full Text] [Related]
33. Factors indicating renal injury in pediatric bilateral ureteropelvic-junction obstruction.
Lee YS; Jeong HJ; Im YJ; Kim MJ; Lee MJ; Yun M; Han SW
Urology; 2013 Apr; 81(4):873-8. PubMed ID: 23395124
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis of ureteropelvic junction obstruction in children: role of endothelin-1 in voided urine.
Taha MA; Shokeir AA; Osman HG; Abd el-Aziz Ael-A; Farahat SE
Urology; 2007 Mar; 69(3):560-4; discussion 564-5. PubMed ID: 17382166
[TBL] [Abstract][Full Text] [Related]
35. Conservative treatment of ureteropelvic junction obstruction in children with antenatal diagnosis of hydronephrosis: lessons learned after 16 years of follow-up.
Chertin B; Pollack A; Koulikov D; Rabinowitz R; Hain D; Hadas-Halpren I; Farkas A
Eur Urol; 2006 Apr; 49(4):734-8. PubMed ID: 16504374
[TBL] [Abstract][Full Text] [Related]
36. Urinary and serum biomarkers in ureteropelvic junction obstruction: a systematic review.
Papachristou F; Pavlaki A; Printza N
Biomarkers; 2014 Nov; 19(7):531-40. PubMed ID: 25082300
[TBL] [Abstract][Full Text] [Related]
37. The use of urinary osmolality to evaluate postoperative renal function in children with ureteropelvic junction obstruction.
Pérez-Etchepare Figueroa EL; Moraleda Mesa T; Hernández Rodríguez RA; Rosell Echevarría MJ; Tejera Carreño P; Luis Yanes MI; Monge Zamorano M; García Nieto VM
J Pediatr Urol; 2021 Aug; 17(4):513.e1-513.e7. PubMed ID: 34244058
[TBL] [Abstract][Full Text] [Related]
38. A novel urinary biomarker protein panel to identify children with ureteropelvic junction obstruction - A pilot study.
Devarakonda CKV; Shearier ER; Hu C; Grady J; Balsbaugh JL; Makari JH; Ferrer FA; Shapiro LH
J Pediatr Urol; 2020 Aug; 16(4):466.e1-466.e9. PubMed ID: 32620509
[TBL] [Abstract][Full Text] [Related]
39. Serum and urinary thioredoxin concentrations are associated with severity of children hydronephrosis.
Xu ZM; Li MJ; Tao C
Clin Chim Acta; 2017 Mar; 466():127-132. PubMed ID: 28111273
[TBL] [Abstract][Full Text] [Related]
40. [Diagnosis and treatment of ureteropelvic junction obstruction caused by renal crossing vessels:an analysis of 24 cases].
Qiu M; Wu H; Ma L; Lu J; Huang Y; Li G; Yan Y; Li H
Zhonghua Wai Ke Za Zhi; 2014 Sep; 52(9):702-5. PubMed ID: 25410785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
